Growth Metrics

Oculis Holding AG (OCS) Assets (2021 - 2026)

Quarterly Assets rose 37.21% to $311.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $311.6 million through Mar 2026, up 37.21% year-over-year, with the annual reading at $295.2 million for FY2025, 114.89% up from the prior year.

Oculis Holding AG's Assets history spans 6 years, with the latest figure at $311.6 million for Q1 2026.

  • Assets came in at $311.6 million for Q1 2026, up from $295.2 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $311.6 million in Q1 2026 to a low of $38.5 million in Q4 2022.
  • The 5-year median for Assets is $150.0 million (2023), against an average of $175.0 million.
  • Year-over-year, Assets tumbled 38.89% in 2022 and then soared 235.12% in 2023.
  • Oculis Holding AG's Assets stood at $38.5 million in 2022, then skyrocketed by 235.12% to $128.9 million in 2023, then grew by 6.57% to $137.4 million in 2024, then skyrocketed by 114.89% to $295.2 million in 2025, then increased by 5.54% to $311.6 million in 2026.
  • Per Business Quant, the three most recent readings for OCS's Assets are $311.6 million (Q1 2026), $295.2 million (Q4 2025), and $209.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 14.93 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 37.37 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.73 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 78.88 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 33.89 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 26.48 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 40.87 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 23.64 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 5.13 Bn
10 Oculis Holding AG 24.51 Bn 24.21 Bn - 311.58 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 311.58 Mn
Dec 31, 2025 295.23 Mn
Sep 30, 2025 209.81 Mn
Jun 30, 2025 219.38 Mn
Mar 31, 2025 227.09 Mn
Dec 31, 2024 137.39 Mn
Sep 30, 2024 144.98 Mn
Jun 30, 2024 153.41 Mn
Mar 31, 2024 113.09 Mn
Dec 31, 2023 128.92 Mn
Sep 30, 2023 145.98 Mn
Jun 30, 2023 149.97 Mn
Dec 31, 2022 38.47 Mn
Dec 31, 2021 62.95 Mn